期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
舒血宁注射液联合布地奈德福莫特罗粉吸入剂对AECOPD患者肺功能及血清MCP-1、BMP-2水平的影响 被引量:5
1
作者 聂言臣 王宗立 《浙江中西医结合杂志》 2019年第7期552-554,共3页
慢性阻塞性肺疾病(COPD)为临床常见呼吸系统疾病,多发于40岁以上人群,以持续气流受限为主要特征,可引起慢性咳嗽、呼吸困难、气短、喘息、咳痰等症状,该病呈进行性发展,致残、致死率均较高[1]。在病毒或细菌等感染诱导下,稳定期COPD可... 慢性阻塞性肺疾病(COPD)为临床常见呼吸系统疾病,多发于40岁以上人群,以持续气流受限为主要特征,可引起慢性咳嗽、呼吸困难、气短、喘息、咳痰等症状,该病呈进行性发展,致残、致死率均较高[1]。在病毒或细菌等感染诱导下,稳定期COPD可进展为急性加重期COPD(AECOPD),急性加重期患者病情较为严重,肺功能明显降低,易引发呼吸衰竭、多器官功能障碍、全身炎症反应综合征等严重并发症,甚至危及患者生命,需及时给予有效治疗[2]。布地奈德福莫特罗粉吸入剂是临床治疗AECOPD的常用药物,其单独治疗AECOPD的疗效不尽理想[3-4]。笔者运用舒血宁注射液联合布地奈德福莫特罗粉吸入剂治疗AECOPD效果明显,报道如下。 展开更多
关键词 AECOPD 舒血宁注射液 布地奈德福莫特罗粉吸入剂 肺功能 炎性因子 气道重塑分子
下载PDF
百令胶囊联合布地奈德吸入气雾剂治疗稳定期COPD患者的临床效果 被引量:1
2
作者 郝颖 杨少朋 +1 位作者 于超 侯云鹤 《中国民康医学》 2021年第16期71-73,共3页
目的:观察布地奈德吸入气雾剂联合百令胶囊治疗稳定期慢性阻塞性肺疾病(COPD)患者的临床效果。方法:选取110例稳定期COPD患者作为研究对象,以随机数字表法分为对照组和观察组各55例。对照组予以布地奈德吸入气雾剂治疗,观察组在对照组... 目的:观察布地奈德吸入气雾剂联合百令胶囊治疗稳定期慢性阻塞性肺疾病(COPD)患者的临床效果。方法:选取110例稳定期COPD患者作为研究对象,以随机数字表法分为对照组和观察组各55例。对照组予以布地奈德吸入气雾剂治疗,观察组在对照组基础上联合百令胶囊治疗,比较两组治疗前后肺功能指标[第1秒用力呼气容积(FEV_(1))、FEV_(1)/用力肺活量(FVC)]水平、血清气道重塑分子[转化生长因子-β1(TGF-β1)、基质金属蛋白酶-9(MMP-9)、烟酰胺腺嘌呤二核苷酸磷酸氧化酶4(NOX4)、核因子-κB(NF-κB)]水平和不良反应发生率。结果:治疗后,观察组FEV_(1)、FEV_(1)/FVC均大于对照组,TGF-β1、MMP-9、NOX4和NF-κB水平均低于对照组,差异有统计学意义(P<0.05);两组治疗期间均未出现严重不良反应。结论:布地奈德吸入气雾剂联合百令胶囊治疗稳定期COPD患者可提高肺功能指标水平,降低血清气道重塑分子水平,效果优于单纯布地奈德吸入气雾剂治疗。 展开更多
关键词 慢性阻塞性肺疾病 稳定期 布地奈德吸入气雾剂 百令胶囊 血清气道重塑分子 不良反应
下载PDF
Investigation of the active components and mechanism of Sanao Decoction in treating chronic cough by network pharmacology and molecular docking 被引量:2
3
作者 SHENG Mengke LIU Xing +4 位作者 LIAO Yuyao LI Zhixun LYU Lijing YANG Jiaqi SHI Xinyuan 《Digital Chinese Medicine》 2021年第3期191-201,共11页
Objective To investigate the active components and mechanism of Sanao Decoction(三拗汤,SAD)in treating chronic cough based on network pharmacology and molecular docking.Methods Active components and their targets were... Objective To investigate the active components and mechanism of Sanao Decoction(三拗汤,SAD)in treating chronic cough based on network pharmacology and molecular docking.Methods Active components and their targets were obtained from the Traditional Chinese Medicine Systems and Pharmacology Database and Analysis Platform(TCMSP),Bioinformatics Analysis Tool for Molecular mech ANism of Traditional Chinese Medicine(BATMAN-TCM)database,and the literature.The component-target regulatory network and protein-protein interaction(PPI)network were constructed by Cytoscape 3.7.2,and a bioinformatics analysis was performed to identify the significant pathways and their relevant targets.Molecular docking of the core active components and relevant targets was performed.Results A total of 98 active components of SAD and the corresponding 113 drug targets were identified.The component-target regulatory network and PPI network were successfully established.Results of the bioinformatics analysis indicated that 2281 Gene Ontology(GO)terms were enriched in chronic cough,including 2062 terms were in biological processes,77 in cellular components,and 142 in molecular functions,and top 20 significant pathways in Kyoto Encyclopedia of Genes and Genomes(KEGG)analysis.Molecular docking study demonstrated that quercetin,luteolin,kaempferol,and naringenin were in good agreement with the corresponding targets.Conclusion The active compounds of SAD,such as quercetin,luteolin,kaempferol,and naringenin,may act on AKT1,MAPK1,RELA,EGFR,and Bcl-2 and regulate the PI3 K-Akt signaling pathway,AGE-RAGE signaling pathway,and fluid shear stress and atherosclerosis pathway to exert the effects of anti-inflammatory,anti-airway remodeling,anti-oxidant stress effects,and repair airway damage,thus treating chronic cough. 展开更多
关键词 Sanao Decoction(三拗汤 SAD) Chronic cough Network pharmacology Molecular docking Anti-airway remodeling Anti-oxidant stress Repair airway damage
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部